Form 4: Director Carlos Alban Exercises Solventum RSUs

Solventum Corp Director Carlos Alban acquired 3,403 shares of common stock through the vesting and settlement of restricted stock units.

Summary

• Director Carlos Alban acquired 3,403 shares of Solventum Corp (SOLV) common stock.
• The acquisition resulted from the settlement of vested Restricted Stock Units (RSUs).
• The transaction occurred on April 30, 2026, at a price of $0 per share.
• Following this transaction, Carlos Alban holds a total of 8,947 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing standard equity compensation settlement for a board member.

Positives

• Director maintains a direct equity stake in the company, aligning interests with shareholders.
• The transaction reflects the settlement of previously granted equity compensation.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

Not applicable as this is a routine disclosure of insider equity transactions.

Industry Context

StockSavvy.ai notes that routine RSU vesting for directors is a standard corporate governance practice and does not typically signal a change in strategic direction or market sentiment.

Comparison to Industry Standards

• The transaction is consistent with standard executive and director compensation practices in the healthcare and medical technology sectors.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine equity settlement.

Next Steps

• None identified.

Key Dates

Keywords

Solventum, SOLV, Form 4, Insider Trading, Director, Restricted Stock Units